[{"NetIncomeLoss_1_Q2_USD":-32284209.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":26.38,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":186299331.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-48872.0,"Depreciation_2_Q2_USD":18075.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":955213.0,"AssetsCurrent_0_Q2_USD":141654894.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q2_USD":10162831.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4786652.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":958895.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":2300208.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":1156458.0,"DebtInstrumentUnamortizedDiscountNoncurrent_0_Q2_USD":1562184.0,"CommonStockSharesIssued_0_Q2_shares":37648948.0,"Assets_0_Q2_USD":143264750.0,"ShareBasedCompensation_2_Q2_USD":9187339.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1209037.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":63.58,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":7212367.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":48.74,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":34296.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"InterestPaidNet_2_Q2_USD":2312917.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":530437.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":37595069.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37512716.0,"ResearchAndDevelopmentExpense_2_Q2_USD":31099014.0,"ResearchAndDevelopmentExpense_1_Q2_USD":14503326.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":26.35,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1205000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":3765.0,"InvestmentIncomeNet_2_Q2_USD":-2852431.0,"InvestmentIncomeNet_1_Q2_USD":-1436522.0,"InterestPayableCurrent_0_Q2_USD":381250.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":10000551.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1892026.0,"OperatingIncomeLoss_2_Q2_USD":-58691748.0,"OtherAssetsNoncurrent_0_Q2_USD":317375.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":81863.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":411773127.0,"Cash_0_Q2_USD":141219090.0,"Liabilities_0_Q2_USD":71828130.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q2_shares":8647.0,"OperatingLeaseLiability_0_Q2_USD":1170704.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":18045379.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":13.19,"GeneralAndAdministrativeExpense_2_Q2_USD":27592734.0,"GeneralAndAdministrativeExpense_1_Q2_USD":16344361.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":141219090.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":15541.0,"OperatingIncomeLoss_1_Q2_USD":-30847687.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":66.05,"AmortizationOfFinancingCosts_2_Q2_USD":292870.0,"AmortizationOfFinancingCosts_1_Q2_USD":149281.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":87.76,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":84010.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5456242.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-52609042.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":630000.0,"LiabilitiesCurrent_0_Q2_USD":22863668.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":145918708.0,"AccountsPayableCurrent_0_Q2_USD":11611996.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":435804.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":2872194.0,"LongTermDebtNoncurrent_0_Q2_USD":48882599.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.06,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":185891183.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":141200000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":80.43,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":162503.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":12193153.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":83444.0,"NetIncomeLoss_2_Q2_USD":-61544179.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":4455816.0,"CommonStockSharesOutstanding_0_Q2_shares":37648948.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-42657363.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-340340272.0,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":17.67,"OperatingLeaseCost_2_Q2_USD":573846.0,"OperatingLeaseCost_1_Q2_USD":286923.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":143264750.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3034669.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":19761468.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":9187339.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5456242.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":57000000.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_2_Q2_USD":1449582.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":560752.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1088841.0,"OperatingExpenses_2_Q2_USD":58691748.0,"OperatingExpenses_1_Q2_USD":30847687.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.64,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.86,"ProfitLoss_2_Q2_USD":-61544179.0,"StockholdersEquity_0_Q2_USD":71436620.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":48872.0,"DebtInstrumentCarryingAmount_0_Q2_USD":50000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4461985.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2670402.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":55727.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":575000.0,"Ticker":"AXSM","CIK":"1579428","name":"AXSOME THERAPEUTICS, INC.","OfficialName":"Axsome Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1574461367.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]